Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Tranexamic Acid (TXA) in Hip Fractures, A Double-Blind, Randomized Controlled Trial

NCT02993341 is registered in ClinicalTrials.gov with Sault Area Hospital as lead sponsor.

NCT NCT02993341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Tranexamic Acid (TXA) in Hip Fractures, A Double-Blind, Randomized Controlled Trial
Lead sponsor
Sault Area Hospital
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2016
Completion date
Not reported
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hip fracture